Relocated Biology

The big Stago family integrates Point-of-Care systems

Need a rapid diagnosis of haemostasis and coagulopathy especially closer to the patient?

In Australia and New Zealand, it's Stago who distributes the first Point-Of-Care (Quantra) developed and produced by HemoSonics, a subsidiary of the Stago Group.

The Quantra system can guide experts in massive perioperative bleeding in their care of patients. The range of tests available makes it possible to evaluate the hemostatic profile of their patients via easily interpretable and reliable results in less than 15 minutes.
Based on patented ultrasound technology (SEER *), Quantra is fully automated and easily used by all healthcare professionals from a single whole blood sample.

Technological innovation at the service of the emergency therapeutic decision.
For more information go to

* Sonic Estimation of Elasticity via Resonance.